G`opirjonova D.D, G`opirjonova D.D, Alyavi A.L, Alyavi A.L (2024) YURAK ISHEMIK KASALLIGI MAVJUD BEMORLARDA INTERLEYKIN-6 AHAMIYATI. "Conference on Universal Science Research 2023", 2 (5). pp. 92-95.
![[thumbnail of 92-95_G_opirjonova_D_KONFERENSIYA_CUSR.pdf]](https://arxiv.universalpublishings.com/style/images/fileicons/application_pdf.png)
PDF
92-95_G_opirjonova_D_KONFERENSIYA_CUSR.pdf - Published Version
Download (467kB)
Annotatsiya
Yallig`lanish bu yurak ishemik kasalligida (YuIK) ishtirok etuvchi muhim jarayon hisoblanadi. Metabolik stress, gemodinamik ortiqcha yuk va endoteliy va miyokard hujayralarida neyrogumaral giperaktivatsiyaga javoban interleykin (IL) 1 va 6 kabi yallig`lanishga qarshi sitokinlar chiqariladi. Dastlab, bu jarayon organizimni stresga moslashishini taminlaydi, ammo keyinchlik kasallik davrida ular endothelial va yurak disfunktsiyasi orqali miyokard fibroziga olib keladigan zararli ta`sirlarni keltirib chiqaradi. Tadqiqotlar shuni ko`rsatadiki yurak ishemik kasalligida bemorlarda interleykin(IL)6 yallig`lanish mediatori ko`payib ketadi.
| Hujjat turi: | Maqola |
|---|---|
| Mualliflar: | Muallif Email G`opirjonova D.D, G`opirjonova D.D UNSPECIFIED Alyavi A.L, Alyavi A.L UNSPECIFIED |
| Jurnal / Nashr: | "Conference on Universal Science Research 2023" |
| Jild: | 2 |
| Soni: | 5 |
| Sahifalar: | pp. 92-95 |
| Sana: | 15 May 2024 |
| Kalit so'zlar: | Yurak ishemik kasalligi, biomarkerlar, yallig`lanish, interleykin-6 |
| URI: | https://arxiv.universalpublishings.com/id/eprint/100047 |
![[pin missing: title]](/style/images/action_view.png)
- [pin missing: title]